Your browser is no longer supported. Please, upgrade your browser.
Settings
CORT Corcept Therapeutics Incorporated daily Stock Chart
CORT [NASD]
Corcept Therapeutics Incorporated
Index- P/E86.06 EPS (ttm)0.29 Insider Own0.70% Shs Outstand112.22M Perf Week19.61%
Market Cap2.77B Forward P/E28.23 EPS next Y0.88 Insider Trans-5.53% Shs Float103.17M Perf Month56.63%
Income35.40M PEG1.21 EPS next Q0.18 Inst Own67.10% Short Float16.83% Perf Quarter34.97%
Sales129.70M P/S21.37 EPS this Y216.90% Inst Trans0.52% Short Ratio9.52 Perf Half Y90.44%
Book/sh0.76 P/B32.50 EPS next Y106.86% ROA41.50% Target Price20.75 Perf Year233.78%
Cash/sh0.67 P/C36.86 EPS next 5Y71.00% ROE58.20% 52W Range6.70 - 24.02 Perf YTD36.77%
Dividend- P/FCF69.12 EPS past 5Y16.90% ROI18.10% 52W High2.83% Beta1.69
Dividend %- Quick Ratio3.70 Sales past 5Y- Gross Margin97.70% 52W Low268.66% ATR1.07
Employees103 Current Ratio3.90 Sales Q/Q97.20% Oper. Margin27.90% RSI (14)83.51 Volatility6.02% 5.19%
OptionableYes Debt/Eq0.00 EPS Q/Q393.20% Profit Margin27.30% Rel Volume1.36 Prev Close23.98
ShortableYes LT Debt/Eq0.00 EarningsFeb 01 AMC Payout0.00% Avg Volume1.82M Price24.70
Recom2.00 SMA2026.65% SMA5035.28% SMA20064.15% Volume2,470,113 Change3.00%
Aug-31-17Initiated Stifel Buy $20
Feb-02-17Initiated Ladenburg Thalmann Buy $14
Apr-21-15Initiated FBR Capital Outperform $12
Jan-13-14Downgrade Stifel Buy → Hold
Aug-09-13Downgrade Ladenburg Thalmann Buy → Neutral $3.30
Aug-09-13Downgrade Janney Buy → Neutral
Feb-21-12Reiterated JMP Securities Mkt Outperform $9 → $11
Jan-06-10Upgrade Ladenburg Thalmann Neutral → Buy $4
Jul-17-08Initiated Rodman & Renshaw Mkt Outperform $8
Jun-21-07Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
Jan-18-18 12:24PM  Harry Boxers four breakout stocks to watch include Universal Display MarketWatch +6.26%
Jan-10-18 05:59PM  Corcept Therapeutics Stock Has Healthy Institutional Support Investopedia
Jan-05-18 08:10AM  Analysis: Positioning to Benefit within Perry Ellis International, AutoZone, Corcept Therapeutics, LCI Industries, LegacyTexas Financial Group, and Micronet Enertec Technologies Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-03-18 10:03AM  Trevena Announces FDA Acceptance of Olinvo NDA, Shares Up Zacks
09:55AM  Achaogen's NDA for Plazomicin Gets Priority Review From FDA Zacks
Dec-29-17 11:45AM  ETFs with exposure to Corcept Therapeutics, Inc. : December 29, 2017 Capital Cube
09:55AM  TherapeuticsMD Submits NDA for VMS Candidate, Shares Rise Zacks
Dec-28-17 07:05PM  What Should We Expect From Corcept Therapeutics Incorporateds (NASDAQ:CORT) Earnings Over The Next Few Years? Simply Wall St.
09:45AM  Actinium Posts Positive DMC View on Lomab-B Phase III Trial Zacks
09:21AM  Horizon Pharma Gets FDA Nod for Procysbi Label Expansion Zacks
Dec-27-17 11:29AM  Insys' Cannabidiol Gets Fast Track Designation in the U.S. Zacks -6.23%
08:14AM  Why is Corcept's Stock Up More Than 150% So Far This Year? Zacks
08:11AM  Alexion's (ALXN) Soliris Label Expansion Approved in Japan Zacks
Dec-26-17 09:45AM  Merck's Diabetes Drugs Get FDA Nod as Adjunct Therapies Zacks +5.03%
09:17AM  BioMarin's (BMRN) Pegvaliase Review Period Extended by FDA Zacks
Dec-25-17 07:17AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CORT-US : December 25, 2017 Capital Cube
Dec-22-17 08:30AM  Strength Seen in Corcept Therapeutics (CORT): Stock Soars 10.8% Zacks
03:00AM  Corcept Therapeutics Shows Rising Price Performance With Jump To 95 RS Rating Investor's Business Daily
Dec-21-17 05:20PM  Why Corcept Therapeutics Shares Climbed 10.8% Today Motley Fool +10.82%
04:15PM  This Biotech Stock Launched After Joining The S&P 600 SmallCap Investor's Business Daily
10:35AM  Allergan/Paratek's Acne Candidate NDA Filing Accepted by FDA Zacks
Dec-20-17 05:44PM  Interactive Brokers Group Set to Join S&P MidCap 400; Alarm.com Holdings and Corcept Therapeutics to Join S&P SmallCap 600 PR Newswire
Dec-19-17 09:53AM  Regeneron in Strategic Immuno-Oncology Collaboration With ISA Zacks
09:28AM  Alnylam/Sanofi Submit MAA in Europe for RNAi Candidate Zacks
Dec-18-17 05:52PM  Novartis (NVS) Oncology Head Strigini to Step Down by Dec. 31 Zacks
05:45PM  Radius Health to Get Third Day-180 List of Outstanding Issues Zacks
09:37AM  Spectrum Pharma Dismisses CEO, Makes Leadership Changes Zacks
Dec-13-17 05:45PM  Regeneron, Sanofi Report Positive Top Line Skin Cancer Data Zacks
03:46PM  Allergan Inks Deal to Buy Texas-Based Repros Therapeutics Zacks
01:01PM  ETFs with exposure to Corcept Therapeutics, Inc. : December 13, 2017 Capital Cube
09:40AM  Glaxo's Nucala Label Expansion Application Gets FDA Approval Zacks
Dec-12-17 05:58PM  Merck's Keytruda Gets FDA Priority Review for Rare Lymphoma Zacks
10:15AM  Spark Therapeutics Stock Plunges on Hemophilia Therapy Data Zacks
Dec-11-17 02:12PM  Lilly Reports Mixed Results from Late-Stage Cyramza Study Zacks
Dec-07-17 04:28PM  5 Health Care Stocks Gurus Are Buying GuruFocus.com
02:21PM  Roche Reports Tecentriq/Avastin Lung Cancer Study Data Zacks
Dec-06-17 02:10PM  Revance's Neuromodulator Injection Positive in Phase III Zacks
Dec-05-17 09:46AM  Here's Why Sarepta Stock is Up More Than 70% in 6 Months Zacks
09:05AM  Ironwood Succeeds in Diabetic Hypertension Phase II Study Zacks
Dec-04-17 08:07AM  3 Highest Growth Stocks in the Market Today Motley Fool -8.35%
Dec-01-17 06:14PM  Bristol-Myers' Opdivo's Lung Cancer Study Meets Early Success Zacks
05:51PM  Celldex Begins Phase I Trial on Cancer Candidate CDX-1140 Zacks
Nov-29-17 09:52AM  AstraZeneca's Tagrisso Label Expansion Filing Accepted by EMA Zacks
Nov-22-17 08:42AM  Valeant Closes Senior Note Offering, Reprices Term Loan Zacks
Nov-21-17 12:37PM  Edited Transcript of CORT earnings conference call or presentation 2-Nov-17 9:00pm GMT Thomson Reuters StreetEvents
09:15AM  Can Valeant (VRX) Turn Around on Rebuilding Initiatives? Zacks
Nov-20-17 04:07PM  Mallinckrodt (MNK) Down 55% Year to Date: What Lies Ahead? Zacks -7.07%
10:02AM  Roche Reports Positive Data From Tecentriq Combination Study Zacks
08:10AM  Todays Research Reports on Trending Tickers: Catalyst Biosciences and Corcept Therapeutics ACCESSWIRE
07:57AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : November 20, 2017 Capital Cube
Nov-17-17 09:01AM  Alnylam Starts Rolling NDA Submission for RNAi Candidate Zacks
Nov-16-17 07:55AM  Incyte (INCY) Initiates Essential Thrombocythemia Trial Zacks
Nov-15-17 12:07PM  Valeant (VRX) Announces Pricing of Senior Secured Notes Zacks
11:20AM  Roche (RHHBY) Receives FDA Clearance for Ventana MMR Test Zacks
10:19AM  Pacira's Exparel sNDA to be Reviewed by FDA Advisory Committee Zacks
06:36AM  Cardinal Health (CAH) to Divest Assets to Shanghai Pharma Zacks
Nov-14-17 10:09AM  Shire Gets Positive CHMP Opinion for Hemophilia A Drug Zacks
10:05AM  Alnylam RNAi Drug Gets Accelerated Assessment Grant From EMA Zacks
09:48AM  Glaxo's Subcutaneous Formulation of Benlysta Approved in EU Zacks
Nov-13-17 12:05PM  ETFs with exposure to Corcept Therapeutics, Inc. : November 13, 2017 Capital Cube
Nov-10-17 07:55AM  The Zacks Analyst Blog Highlights: Micron Technology, Meritor, RH, Ultra Clean Holdings and Corcept Therapeutics Zacks
Nov-09-17 04:25PM  5 Stocks That Doubled in 2017 and Can Keep Soaring Higher Zacks
07:10AM  Featured Company News Nektar Presented Preclinical Data on NKTR-358 at 2017 American College of Rheumatology Annual Meeting ACCESSWIRE
Nov-08-17 10:52AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : November 8, 2017 Capital Cube
Nov-07-17 08:15AM  Corcept Therapeutics, Inc. :CORT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-06-17 08:00AM  Today's Research Reports on Stocks to Watch: Clean Energy Fuels Corp. and Corcept Therapeutics ACCESSWIRE +5.08%
07:48AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CORT-US : November 6, 2017 Capital Cube
Nov-03-17 03:32PM  Why Investors Should Be Excited About Corcept Therapeutics Plunging as Much as 18% Motley Fool -12.13%
03:14PM  Corcept (CORT) Q3 Earnings Miss Estimates, Guidance Raised Zacks
Nov-02-17 06:58PM  Corcept misses 3Q profit forecasts Associated Press
05:34PM  Small-Cap Biotech Dips As Sales Top, But Earnings Miss By 2 Cents Investor's Business Daily
04:05PM  Corcept Therapeutics Announces Third Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update GlobeNewswire
Nov-01-17 12:01PM  ETFs with exposure to Corcept Therapeutics, Inc. : November 1, 2017 Capital Cube
Oct-26-17 04:05PM  Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Oct-24-17 07:33AM  3 Small, Profitable Biotechs With Fantastic Growth Motley Fool
Oct-20-17 10:09AM  ETFs with exposure to Corcept Therapeutics, Inc. : October 20, 2017 Capital Cube
Oct-16-17 08:20AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and Orexigen Therapeutics ACCESSWIRE +5.30%
Oct-10-17 04:01PM  Weakness In Corcept Shares Is 'Overdone,' According To Analyst Benzinga -5.94%
01:39PM  Can Corcept Therapeutics Incorporateds (CORT) ROE Continue To Surpass The Industry Average? Simply Wall St.
Oct-09-17 11:24AM  ETFs with exposure to Corcept Therapeutics, Inc. : October 9, 2017 Capital Cube
Oct-06-17 09:03AM  Corcept Therapeutics, Inc. :CORT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-27-17 03:00AM  Stocks Showing Market Leadership: Sarepta Therapeutics Earns 91 RS Rating Investor's Business Daily
03:00AM  Stocks Flashing Renewed Technical Strength: Innoviva Investor's Business Daily
03:00AM  Acceleron Pharma Reaches 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Sep-26-17 07:38AM  Is It Too Late To Buy Corcept Therapeutics Incorporated (CORT)? Simply Wall St.
07:17AM  3 Bargain Biotech Stocks You Can Buy Today Motley Fool
03:00AM  Acorda Therapeutics Getting Closer To Key Technical Measure Investor's Business Daily
Sep-25-17 07:04AM  3 Highest-Growth Stocks in the Market Today Motley Fool +5.11%
Sep-14-17 05:39PM  4 Biotech Stocks That Show Promise on Sustainable Growth Zacks
11:11AM  3 Stocks That Have Doubled This Year Motley Fool
Aug-30-17 12:00PM  Harry Boxers four biotech stocks to watch MarketWatch
09:17AM  Pfizer's sNDA for Bosulif Accepted in the U.S. and Europe Zacks
Aug-29-17 10:36AM  Top Ranked Momentum Stocks to Buy for August 29th Zacks
Aug-28-17 07:04PM  Cramer's lightning round: I know I'm alone here, but I st... CNBC Videos
06:48PM  Cramer's lightning round: I know I'm alone here, but I still like the airlines CNBC
Aug-25-17 11:09AM  Mylan and Otsuka Ink Agreement to Commercialize Deltyba Zacks
10:45AM  Adamas (ADMS) Dyskinesia Drug Gets FDA Approval, Stock Soars Zacks
Aug-24-17 11:55AM  BioDelivery (BDSI) CEO Mark Sirgo to Retire by 2017 End Zacks
10:57AM  Lannett (LCI) Q4 Earnings In Line, Stock Up on Solid View Zacks
10:35AM  4 of the Highest-Growth Stocks in Biotech Today Motley Fool
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. The company is also developing Korlym in combination with eribulin, which is in Phase I/II clinical trial to treat patients with metastatic triple-negative breast cancer; Korlym in combination with drug Abraxane that is in Phase II clinical trial to treat patients with triple-negative breast cancer; and Korlym combined with the androgen deprivation agent enzalutamide, which is in Phase II clinical trial to treat patients with metastatic castration-resistant prostate cancer. In addition, it develops CORT125134 for the treatment of patients with Cushing's syndrome and solid-tumor cancers; and CLIA-validated assay to measure expression of the gene FKBP5, which is stimulated by cortisol activity at glucocorticoid receptor. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FISHMAN ROBERT SChief Medical OfficerJan 08Option Exercise3.518,00028,0808,000Jan 10 05:05 PM
FISHMAN ROBERT SChief Medical OfficerJan 08Sale18.678,000149,3490Jan 10 05:05 PM
FISHMAN ROBERT SChief Medical OfficerDec 08Option Exercise3.518,00028,0808,000Dec 12 05:15 PM
FISHMAN ROBERT SChief Medical OfficerDec 08Sale16.728,000133,7760Dec 12 05:15 PM
BAKER G LEONARD JRDirectorNov 13Option Exercise2.7030,00081,000806,838Nov 15 05:27 PM
BAKER G LEONARD JRDirectorNov 13Sale17.5930,000527,556776,838Nov 15 05:27 PM
MAHONEY DAVID LDirectorJul 19Option Exercise2.2316,91537,7201,152,588Jul 20 09:09 PM
MAHONEY DAVID LDirectorJul 19Sale12.5016,915211,4581,135,673Jul 20 09:09 PM
MAHONEY DAVID LDirectorJul 18Option Exercise2.236,09113,5831,141,764Jul 20 09:09 PM
MAHONEY DAVID LDirectorJul 18Sale12.506,09176,1391,135,673Jul 20 09:09 PM
MAHONEY DAVID LDirectorJul 13Sale12.554846,0731,128,679Jul 14 05:35 PM
MAHONEY DAVID LDirectorJul 12Sale12.506,51081,3751,129,163Jul 14 05:35 PM
Robb Gary CharlesChief Financial OfficerMay 04Buy9.755,60054,5886,858May 08 05:14 PM
ENRIGHT PATRICK GDirectorMar 16Sale9.94269,9552,683,237114,675Mar 20 04:36 PM
ENRIGHT PATRICK GDirectorMar 15Sale10.24279,0202,856,766139,630Mar 15 06:45 PM
ENRIGHT PATRICK GDirectorMar 14Sale10.01300,0003,002,670145,113Mar 15 06:45 PM
ENRIGHT PATRICK GDirectorMar 13Sale11.1320,980233,491151,008Mar 15 06:45 PM
ENRIGHT PATRICK GDirectorMar 08Sale9.75750,0007,312,500151,420Mar 10 04:22 PM
ENRIGHT PATRICK GDirectorFeb 27Sale9.051,000,0009,050,000166,157Feb 27 07:04 PM
ENRIGHT PATRICK GDirectorFeb 23Sale8.651,500,00012,975,000185,807Feb 27 07:04 PM